Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID ▲ | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C0600139 | Prostate carcinoma | CEACAM6 | 4680 | CEA cell adhesion molecule 6 | P40199 |
| C0600139 | Prostate carcinoma | ACLY | 47 | ATP citrate lyase | P53396 |
| C0600139 | Prostate carcinoma | ARSF | 416 | arylsulfatase F | P54793 |
| C0600139 | Prostate carcinoma | OLR1 | 4973 | oxidized low density lipoprotein receptor 1 | P78380 |
| C0600139 | Prostate carcinoma | ALDH7A1 | 501 | aldehyde dehydrogenase 7 family member A1 | P49419 |
| C0600139 | Prostate carcinoma | OPCML | 4978 | opioid binding protein/cell adhesion molecule like | Q14982 |
| C0600139 | Prostate carcinoma | HSD17B7 | 51478 | hydroxysteroid 17-beta dehydrogenase 7 | P56937 |
| C0600139 | Prostate carcinoma | PIK3CB | 5291 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | P42338 |
| C0600139 | Prostate carcinoma | PCYT1A | 5130 | phosphate cytidylyltransferase 1, choline, alpha | P49585 |
| C0600139 | Prostate carcinoma | ENPP2 | 5168 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Q13822 |
| C0600139 | Prostate carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
| C0600139 | Prostate carcinoma | PIK3CG | 5294 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | P48736 |
| C0600139 | Prostate carcinoma | PKD1 | 5310 | polycystin 1, transient receptor potential channel interacting | P98161 |
| C0600139 | Prostate carcinoma | PI4KA | 5297 | phosphatidylinositol 4-kinase alpha | P42356 |
| C0600139 | Prostate carcinoma | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
| C0600139 | Prostate carcinoma | PLAUR | 5329 | plasminogen activator, urokinase receptor | Q03405 |
| C0600139 | Prostate carcinoma | PLA2G1B | 5319 | phospholipase A2 group IB | P04054 |
| C0600139 | Prostate carcinoma | PLD1 | 5337 | phospholipase D1 | Q13393 |
| C0600139 | Prostate carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
| C0600139 | Prostate carcinoma | PPT1 | 5538 | palmitoyl-protein thioesterase 1 | P50897 |
| C0600139 | Prostate carcinoma | MASP1 | 5648 | mannan binding lectin serine peptidase 1 | P48740 |
| C0600139 | Prostate carcinoma | PRSS8 | 5652 | serine protease 8 | Q16651 |
| C0600139 | Prostate carcinoma | PTEN | 5728 | phosphatase and tensin homolog | P60484 |
| C0600139 | Prostate carcinoma | BAAT | 570 | bile acid-CoA:amino acid N-acyltransferase | Q14032 |
| C0600139 | Prostate carcinoma | PTGS2 | 5743 | prostaglandin-endoperoxide synthase 2 | P35354 |
